News India Times

Dr. Sudhir M. Parikh Founder, Chairman & Publisher Ilayas Quraishi Chief Operating Officer Ela Dutt Editor Arun Shah Ahmedabad Bureau Chief Peter Ferreira, Deval Parikh, Freelance Photographers Bhailal M. Patel Executive Vice President Chandrakant Koticha-Rajkot, India Executive Director Business Development Jim Gallentine Business Development Manager - U.S. M.P. Singh Chauhan Manager Business Development - Ahmedabad Shahnaz Sheikh Senior Manager Advertising & Marketing Sonia Lalwani Advertising Manager Shailu Desai Advertising New York Muslima Shethwala Syed Sheeraz Mahmood Advertising Chicago Digant Sompura Consultant for Business Development Ahemdabad, India Hervender Singh Circulation Manager Main Office Editorial & Corporate Headquarters 35 Journal Square, Suite 204, Jersey City, New Jersey 07306 Tel. (212) 675-7515 Fax. (212) 675-7624 New York Office 3601 36 Ave, Long Island City, NY 11106 Tel: (718) 784-8555 E-mails Website Chicago Office 2652 West Devon Avenue, Suite B Chicago, IL 60659 Tel. (773) 856-3345 California Office 650 Vermont Ave, Suite #46 Anaheim, CA 92805 Mumbai Office Nikita Ajay Pai Goregaon, West Mumbai Ahmedabad Office 303 Kashiparekh Complex C.G. Road, 29 Adarsh Society Ahmedabad 380009 Tel. 26446947 F ax. 26565596 Published weekly, Founded in 1975. The views expressed on the opinion pages are those of the writers and do not necessarily reflect those of News India Times. Copyright © 2020, News India Times News India Times (ISSN 0199-901X) is published every Friday by Parikh Worldwide Media LLC., 35 Journal Square, Suite 204, Jersey City, NJ 07306 Periodicals postage paid at Newark, N.J. , and at additional mailing offices. Postmaster: Send address change to News India Times, 35 Journal Square, Suite 204, Jersey City, NJ 07306 Annual Subscription: United States: $28 Disclaimer: Parikh Worldwide Media assumes no liability for claims/ assumptions made in advertisements and advertorials. – that’s all you need to know Vaccines Prove U.S. Is Still Capable Of Big Accomplishments V eterans Day marks eight months since theWorld Health Organiza- tion declared the novel coronavi- rus to be a pandemic. The United States has lost nearly a quarter- million people; medical experts predict that we will surpass the nation’s combat death toll fromWorldWar II by the end of this year. Ten years ago, a general pessimism began to set in among some pundits and technologists who convinced themselves that America can’t do big things anymore. But they only got it half right. Although the U.S. had created digital services like Facebook, these thinkers noted, massive technological efforts to match the scale of the Manhattan Project to develop nuclear weapons, the Apollo moon landings, or big infrastructure proj- ects like the Hoover Dam or the interstate highway system, seemed out of reach in the modern era. Countries like China boasted massive dams and ultra-fast trains, while the U.S. could barely repair its roads or keep Amtrak running. This concern was shared by figures as diverse as Silicon Valley billionaire Peter Thiel and President Barack Obama. When the Covid-19 pandemic hit and the U.S. seemed unable to carry out mass testing or even produce enough masks for hos- pital workers, the perception of American ineffectuality was reinforced. But then, this month, that changed. Researchers at Moderna Inc. and Pfizer Inc. both announced preliminary results showing that their Covid-19 vaccines are more than 90% effective against the pandemic virus. The first shots could start going into Americans’ arms within weeks. This is a monumental feat. Typically, developing a vaccine takes 10 to 15 years, and the fastest ever recorded previously was four years (not counting variations on existing vaccines such as flu shots). This time, multiple vaccines were created in less than a year. And unlike China, which also developed vaccines very quickly, American researchers used a whole new type of vaccine, which will be hugely use- ful against future pandemics. This was not solely a U.S. accomplish- ment; Pfizer partnered with the German company BioNTech SE, and funding came from the German government. But the development was possible in part because the U.S. Biomedical Advanced Research and Development Authority committed up front to buying a large amount of the vaccine if it was successful. And Moderna’s success was the result of an all-American public-private partnership, with the National Institute of Allergy and Infectious Diseases and BARDA both pitching in large amounts of resources. The Covid-19 vaccination effort isn’t the only big thing the U.S. has accomplished in recent years. Solar power, which not so long ago was so expensive that it was treated as a mere environmentalist pipe dream, has come down in price by a factor of 300 since the late 1970s. In just the last decade, solar costs have declined by over 80%, while battery storage has fallen even faster in price: While some of the solar-cost decline has been due to China producing panels on a massive scale, much of it was due to research funded by the U.S. government. The same is true of advances in lithium- ion batteries, where one American company in particular -- Tesla Inc. -- has been instrumental in pushing down costs. Together, solar and batteries promise to spark a true energy revolution, which will not just help save the world from climate change, but will bring back the days when society could expect cheaper energy every year. And much of this revolution was due, once again, to U.S. public-private partner- ships and decades of far-sighted effort. Covid-19 vaccines and cheap, clean energy are the modern-day Manhattan and Apollo projects. They prove the U.S. can still do big things when it wants to -- at least, in science and technology. But there is one important area in which Americans have lost their ability to get big things done. Thanks to out-of- control construction costs, the nation has been unable to build the type of monumental infrastructure projects that powered growth in past eras. Many of the important undertakings facing the gov- ernment -- building a modernized energy grid, creating denser housing and public transit in the suburbs, retrofitting build- ings to use electricity instead of gas, and cleaning up lead pollution -- will founder if the government can’t find some way to bring down costs, while ideas like high- speed rail will remain pipe dreams. Why can the U.S. do big science but not big infrastructure? It’s mostly a matter of political will. The U.S. allows construction projects to be held up by a near-infinite series of regulatory and legal challenges, causing costly delays. Governments use dysfunctional processes that award contracts to firms that are expensive, overstaffed, and slow. And states generally fail to override the prerogatives of local governments, which are often dominated by politically powerful homeowners who try to prevent anything from being built near their houses. So the U.S. needs to apply the same urgency and political will to construction that it applied to vaccine development. Costly delays and interruptions need to be bypassed or forbidden, inefficient contracting processes must be reformed, and state politicians have to override local ones. Instead of treating construction as a luxury, a jobs program or an opportunity for pork-barrel spending, the government has to make it a priority. America still does big things in the sci- entific realm, but to meet the challenges of the 21st century, it has to be better at building things in the physical world. Noah Smith is a Bloomberg Opinion columnist. He was an as- sistant professor of finance at Stony Brook University, and he blogs at Noahpinion. -Bloomberg TheWashington Post By Noah Smith Opinion News India Times November 27, 2020 3 The VirusWasn’t Spreading In NewYork City Schools. Why Close Them? O nWednesday, NewYork City - with the largest public school district in the country - suspend- ed in-person learning because of rising covid-19 cases in the community. Mayor Bill de Blasio had said schools would close if the positivity rate of corona- virus tests in the city passed 3%, and it did. While rising test positivity is a cause for concern and a reason to increase public health interventions, it can’t be looked at in isolation - and it’s not a good mea- sure on which to base a decision to close schools. The metric is best interpreted as a gauge for how hard we’re looking for cases and how hard it is to find them. It is not equivalent to prevalence of the corona- virus in the community (although it is related to that figure); mainly, it’s a signal to do more testing. The only epidemiological reason to close schools would be evidence that they are magnifying infection and driving community spread. And, so far, there is no data suggesting that in-person educa- tion is doing those things. To the contrary, the prevalence of infection in schools is comparatively low. Given the long-term harms that oc- cur when children are out of school for extended periods (from lower lifetime income to shorter life spans), keeping schools open, as Europe is doing even during its new wave of lockdowns, should be the default. It’s become a cliche to note that bars, restaurants and gyms should close before schools do, but that doesn’t detract from the truth of the observation. De Blasio, a Democrat, said this week that it is “just a matter of time” before the city asks restaurants to close down, but that is cold comfort to parents who must scramble to fulfill their children’s educa- tional needs. Obviously, this argument would not hold if the virus were rampant in schools or streaming from schools to the commu- nity. But it isn’t. The data from NewYork City schools reveals a generally optimistic picture. In the first week of its testing pro- gram, begun last month, only 28 tests out of more than 16,000 conducted returned positive. Nor is there anything inherently special about a 3% positivity rate. It’s an arbitrary metric - and, what’s more, it’s based on testing throughout the city, not schools in particular. It’s also on the conservative side: TheWorld Health Organization has said that governments can consider open- ing up some activities when the rate is below 5%. The positivity rate within New York schools, where an aggressive testing By Amesh A. Adalja - Continued On Page 4